Edgewell Personal Care (EPC) 10-Q 10 May 22 2022 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Mar. 31, 2022	Apr. 30, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-15401
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Incorporation, State or Country Code	MO
Entity Tax Identification Number	43-1863181
Entity Address, Address Line One	6 Research Drive
Entity Address, City or Town	Shelton,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06484
City Area Code	(203)
Local Phone Number	944-5500
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	EPC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		52,802,412
Entity Central Index Key	0001096752
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net sales	$ 547.7	$ 519.3	$ 1,011	$ 970.4
Cost of products sold	317.6	277.6	591	535.4
Gross profit	230.1	241.7	420	435
Selling, general and administrative expense	101.3	93.4	198.2	186.5
Advertising and sales promotion expense	69.9	68.4	116.1	109.6
Research and development expense	13.7	14.3	26.5	28
Restructuring charges	3.5	2.7	5.7	6.4
Operating income	41.7	62.9	73.5	104.5
Interest expense associated with debt	18	17.3	35.3	34.7
Other income, net	(3.4)	0	(5.1)	(1)
Earnings before income taxes	27.1	19.5	43.3	44.7
Income tax provision	3.9	5.1	8.9	12.6
Net earnings	$ 23.2	$ 14.4	$ 34.4	$ 32.1
Basic net earnings per share	$ 0.43	$ 0.26	$ 0.64	$ 0.59
Diluted net earnings per share	$ 0.43	$ 0.26	$ 0.63	$ 0.58
Condensed Consolidated Statements of Comprehensive Income
Net earnings	$ 23.2	$ 14.4	$ 34.4	$ 32.1
Other comprehensive (loss) income, net of tax
Foreign currency translation adjustments	(9)	(19.8)	(15.9)	13.9
Pension and postretirement activity, net of tax	0.1	1.4	0.1	(0.6)
Deferred gain (loss) on hedging activity, net of tax	1	5.1	1.4	3.3
Total other comprehensive (loss) income, net of tax	(7.9)	(13.3)	(14.4)	16.6
Total comprehensive income	$ 15.3	$ 1.1	$ 20	$ 48.7

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Pension and postretirement activity, tax	$ 0.2	$ 0.8	$ 0.3	$ 0
Deferred gain on hedging activity, tax	$ 0.5	$ 2.4	$ 0.6	$ 1.6

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2022	Sep. 30, 2021
Current assets
Cash and cash equivalents	$ 188.1	$ 479.2
Trade receivables, less allowance for doubtful accounts	183.8	150.7
Inventories	429.1	345.7
Other current assets	167.7	160.1
Total current assets	968.7	1,135.7
Property, plant and equipment, net	355.4	362.6
Goodwill	1,340.6	1,162.8
Other intangible assets, net	1,024.2	906.4
Other assets	104.4	107.1
Total assets	3,793.3	3,674.6
Current liabilities
Notes payable	25.8	26.5
Accounts payable	224.7	209.5
Other current liabilities	293.7	300.8
Total current liabilities	544.2	536.8
Long-term debt	1,414.3	1,234.2
Deferred income tax liabilities	139.1	129
Other liabilities	180.2	190.3
Liabilities, Total	2,277.8	2,090.3
Shareholders’ equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,597.2	1,631.1
Retained earnings	883.5	865.7
Common shares in treasury at cost	(814.6)	(776.3)
Accumulated other comprehensive loss	(151.3)	(136.9)
Total shareholders’ equity	1,515.5	1,584.3
Total liabilities and shareholders’ equity	$ 3,793.3	$ 3,674.6

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2022	Sep. 30, 2021
Statement of Financial Position [Abstract]
Trade receivables, less allowance for doubtful accounts	$ 7.8	$ 6.9
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)		65,251,989
Common shares, outstanding (in shares)	52,895,050	54,369,714
Treasury shares (in shares)	12,356,939	10,882,275

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flow from Operating Activities
Net earnings	$ 34.4	$ 32.1
Depreciation and amortization	44.6	44.4
Share-based compensation expense	12.2	12
Loss on sale of assets	0.4	0.4
Deferred compensation payments	(7.1)	(8.8)
Deferred income taxes	(10.5)	(0.8)
Cost of early retirement of long-term debt	0	26.1
Other, net	(0.9)	(1.6)
Change in operating assets and liabilities	(113)	(122.6)
Net cash used by operating activities	(39.9)	(18.8)
Cash Flow from Investing Activities
Capital expenditures	(25)	(22.2)
Acquisition of Billie, net of cash acquired	309.4	0
Proceeds from sale of Infant and Pet Care business	5	7.5
Acquisition of Cremo	0	(0.3)
Collection of deferred purchase price on accounts receivable sold	4.7	2.2
Payments for other investing activities	(1)	(0.8)
Net cash used by investing activities	(325.7)	(13.6)
Cash Flow from Financing Activities
Cash proceeds from the issuance of Senior Notes due 2029	0	500
Cash payments on Senior Notes due 2022	0	(500)
Cash proceeds from debt with original maturities greater than 90 days	399	0
Cash payments on debt with original maturities greater than 90 days	(220)	0
Net increase in debt with original maturities of 90 days or less	0.7	0.7
Debt issuance costs for Senior Notes due 2029	0	(5.9)
Cost of early debt retirement	0	(26.5)
Dividends to common shareholders	(16.7)	(8.4)
Repurchase of shares	(75.4)	(9.2)
Net financing (outflow) inflow from the Accounts Receivable Facility	(0.2)	0.7
Employee shares withheld for taxes	(9.7)	(3)
Proceeds (payments) for other financing activities	0.6	(0.5)
Net cash from (used by) financing activities	78.3	(52.1)
Effect of exchange rate changes on cash	(3.8)	1.9
Net decrease in cash and cash equivalents	(291.1)	(82.6)
Cash and cash equivalents, beginning of period	479.2	364.7
Cash and cash equivalents, end of period	$ 188.1	$ 282.1

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Changes in Shareholders' Equity Statement - USD ($) $ in Millions	Total	Common shares	Treasury shares	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(10,900,000)
Common shares, issued (in shares)		65,200,000
Beginning shareholders' equity at Sep. 30, 2020	$ 1,432.9	$ 0.7	$ (790.4)	$ 1,631.8	$ 782.4	$ (191.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	17.7				17.7
Foreign currency translation adjustments	33.7					33.7
Pension and postretirement activity, net of tax	(2)					(2)
Deferred gain (loss) on hedging activity, net of tax	(1.8)					(1.8)
Dividends declared to common shareholders	(8.5)				(8.5)
Treasury shares repurchased (in usd)	(9.2)		$ (9.2)
Treasury shares repurchased (in shares)			(300,000)
Activity under share plans (shares)			200,000
Activity under share plans (in usd)	2.4		$ 15.4
APIC activity under share plans				(13)
Ending shareholders' equity at Dec. 31, 2020	1,465.2	0.7	(784.2)	1,618.8	791.6	(161.7)
Beginning shareholders' equity at Sep. 30, 2020	1,432.9	0.7	(790.4)	1,631.8	782.4	(191.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	32.1
Foreign currency translation adjustments	13.9
Pension and postretirement activity, net of tax	(0.6)
Deferred gain (loss) on hedging activity, net of tax	3.3
Ending shareholders' equity at Mar. 31, 2021	1,464.1	$ 0.7	$ (781.3)	1,622	797.7	(175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(11,000,000)
Common shares, issued (in shares)		65,200,000
Beginning shareholders' equity at Dec. 31, 2020	1,465.2	$ 0.7	$ (784.2)	1,618.8	791.6	(161.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	14.4				14.4
Foreign currency translation adjustments	(19.8)					(19.8)
Pension and postretirement activity, net of tax	1.4					1.4
Deferred gain (loss) on hedging activity, net of tax	5.1					5.1
Dividends declared to common shareholders	(8.3)				(8.3)
Activity under share plans (shares)			100,000
Activity under share plans (in usd)	6.1		$ 2.9
APIC activity under share plans				3.2
Ending shareholders' equity at Mar. 31, 2021	$ 1,464.1	$ 0.7	$ (781.3)	1,622	797.7	(175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(10,900,000)
Common shares, issued (in shares)		65,200,000
Treasury shares (in shares)	10,882,275		(10,900,000)
Common shares, issued (in shares)	65,251,989	65,200,000
Beginning shareholders' equity at Sep. 30, 2021	$ 1,584.3	$ 0.7	$ (776.3)	1,631.1	865.7	(136.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	11.2				(11.2)
Foreign currency translation adjustments	(6.9)					(6.9)
Deferred gain (loss) on hedging activity, net of tax	0.4					0.4
Dividends declared to common shareholders	(8.4)				(8.4)
Treasury shares repurchased (in usd)	(24.5)		$ (24.5)
Treasury shares repurchased (in shares)			(500,000)
Activity under share plans (shares)			300,000
Activity under share plans (in usd)	(3.8)		$ 33.6
APIC activity under share plans				(37.4)
Ending shareholders' equity at Dec. 31, 2021	1,552.3	0.7	(767.2)	1,593.7	868.5	(143.4)
Beginning shareholders' equity at Sep. 30, 2021	1,584.3	0.7	(776.3)	1,631.1	865.7	(136.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	34.4
Foreign currency translation adjustments	(15.9)
Pension and postretirement activity, net of tax	0.1
Deferred gain (loss) on hedging activity, net of tax	1.4
Treasury shares repurchased (in usd)	$ (75.4)
Treasury shares repurchased (in shares)	(1,900,000)
Ending shareholders' equity at Mar. 31, 2022	$ 1,515.5	$ 0.7	$ (814.6)	1,597.2	883.5	(151.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(11,100,000)
Common shares, issued (in shares)		65,200,000
Beginning shareholders' equity at Dec. 31, 2021	1,552.3	$ 0.7	$ (767.2)	1,593.7	868.5	(143.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	23.2				23.2
Foreign currency translation adjustments	(9)					(9)
Pension and postretirement activity, net of tax	0.1					0.1
Deferred gain (loss) on hedging activity, net of tax	1					1
Dividends declared to common shareholders	(8.2)				(8.2)
Treasury shares repurchased (in usd)	(50.9)		$ (50.9)
Treasury shares repurchased (in shares)			(1,400,000)
Activity under share plans (shares)			100,000
Activity under share plans (in usd)	7		$ 3.5
APIC activity under share plans				3.5
Ending shareholders' equity at Mar. 31, 2022	$ 1,515.5	$ 0.7	$ (814.6)	$ 1,597.2	$ 883.5	$ (151.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)	12,356,939		(12,400,000)
Common shares, issued (in shares)		65,200,000

Background and Basis of Present

Background and Basis of Presentation	6 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. Edgewell operates in more than 20 countries and has a global footprint in more than 50 countries. The Company conducts its business in the following three segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge, Skintimate®, Billie®, Shave Guard and Personna® brands, as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s grooming products, and Wet Ones® products. • Feminine Care includes tampons, pads, and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair statement have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 19, 2021. Acquisition of Billie, Inc. On November 29, 2021, the Company completed the acquisition of Billie, Inc. (“Billie”) (the “Acquisition”), a leading U.S. based consumer brand company that offers a broad portfolio of personal care products for women. The results of Billie for the post-acquisition period are included within the Company’s results since the acquisition date. For more information on the Acquisition, see Note 2 of Notes to Condensed Consolidated Financial Statements. Recently Adopted Accounting Pronouncements. In December 2019, the Financial Accounting Standards Board issued Accounting Standards Update 2019-12, which eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period when interim loss exceeds anticipated loss for the year, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this standard as of October 1, 2021. There was no cumulative effect adjustment recorded to retained earnings as the amount was not material, and the effects of this standard on our financial position, results of operations and cash flows were not material. Statement of Cash Flows Presentation The net presentation of borrowings and repayments under the Company's U.S revolving credit facility in the Condensed Consolidated Statement of Cash Flows for the three months ended December 31, 2021 has been corrected in order to reflect borrowings and repayments on a gross basis, resulting in $93.0 of repayments presented gross that were previously netted against borrowings. Net cash from financing activities reported in the Condensed Consolidated Statement of Cash Flows for the three months ended December 31, 2021 was not impacted and the Company has concluded that this correction is not material to its financial statements.

Business Combinations

Business Combinations	6 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Business Combinations and Divestitures	Business Combinations Billie Inc. On November 29, 2021 (the “Acquisition Date”), the Company completed the Acquisition for cash consideration of $309.4, net of cash acquired. As a result of the Acquisition, Billie became a wholly owned subsidiary of the Company. The Company accounted for the Acquisition utilizing the acquisition method of accounting, which requires assets and liabilities to be recognized based on estimates of their acquisition date fair values. The determination of the values of the acquired assets and assumed liabilities, including goodwill, other intangible assets and deferred taxes, requires significant judgement. The purchase price allocation remains preliminary, as certain information is not yet available. This includes, but is not limited to, the finalization of the fair value of certain assets and liabilities, including the completion of intangible asset valuations. Additionally, tax returns and analyses required to calculate the underlying tax basis of Billie’s assets, liabilities and net operating losses have not been finalized. We expect to complete the purchase price allocation during the 12-month period following the Acquisition Date, during which time the value of the assets and liabilities may be revised as appropriate. The Company used variations of the income approach in determining the fair value of intangible assets acquired in the Acquisition. Specifically, we utilized the multi-period excess earnings method to determine the fair value of the definite lived customer relationships acquired and the relief from royalty method to determine the fair value of the definite lived trade name acquired. Our determination of the fair value of the intangible assets acquired involved the use of significant estimates and assumptions related to revenue growth rates, discount rates, customer attrition rates, and royalty rates. Edgewell believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. The following table provides the preliminary allocation of the purchase price related to the Acquisition based upon the fair value of assets and liabilities assumed: Current assets $ 17.0 Goodwill 181.5 Intangible assets 136.0 Other assets, including property, plant and equipment, net 3.2 Current liabilities (6.9) Deferred tax liabilities (21.4) $ 309.4 The acquired goodwill represented the value of expansion into new markets and channels of trade and is not deductible for tax purposes. The intangible assets acquired consisted primarily of the Billie trade name and customer relationships with a weighted average useful life of 19 years. All assets are included in the Company’s Wet Shave segment. Billie contributed Net sales and a Loss before income taxes totaling $40.9 and $4.4, respectively, for the post-acquisition period ending March 31, 2022 in the Condensed Consolidated Statements of Earnings and Comprehensive Income. The Loss before income taxes was driven primarily by amortization expense of acquired intangible assets. Acquisition and integration costs related to Billie totaling $0.6 and $6.3 were included in Selling, general and administrative expense (“SG&A”) and acquisition costs of $0.5 and $0.8 were included in Cost of products sold in the Condensed Consolidated Statements of Earnings and Comprehensive Income for the three and six months ended March 31, 2022, respectively. The following summarizes the company's unaudited pro forma consolidated results of operations for the three and six months ended March 31, 2022 and March 31, 2021, as though the Acquisition occurred on October 1, 2020: Three Months Ended Six Months Ended 2022 2021 2022 2021 Pro forma net sales $ 547.7 $ 536.2 $ 1,021.0 $ 1,003.5 Pro forma net earnings 23.9 8.2 38.7 18.4

Restructuring Charges

Restructuring Charges	6 Months Ended
	Mar. 31, 2022
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Operating Model Redesign In fiscal 2022, the Company expects to take specific actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency and productivity. As a result of these actions, we expect to incur one-time charges of approximately $15 in fiscal 2022. The Company incurred the following restructuring charges for the three and six months ended March 31, 2022: Three Months Ended Six Months Ended Severance and related benefit costs $ 1.7 $ 3.0 Asset write-off and accelerated depreciation 0.1 0.1 Consulting, project implementation and management, and other exit costs 1.9 2.8 Total restructuring $ 3.7 $ 5.9 Pre-tax SG&A of $0.2 for the three and six months ended March 31, 2022, associated with certain information technology enablement expenses and compensation expenses for restructuring programs were included in Consulting, project implementation and management, and other exit costs. Project Fuel Project Fuel was an enterprise-wide transformational initiative launched in fiscal 2018 to improve operational performance and reshape the business’ cost structure. Project Fuel was completed on September 30, 2021. The Company incurred the following restructuring charges for the three and six months ended March 31, 2021: Three Months Ended Six Months Ended Severance and related benefit costs $ 2.0 4.3 Asset write-off and accelerated depreciation 0.1 0.2 Consulting, project implementation and management, and other exit costs 3.4 5.4 Total restructuring $ 5.5 $ 9.9 Pre-tax SG&A of $2.8 and $3.4 for the three and six months ended March 31, 2021, respectively, associated with certain information technology enablement expenses and compensation expenses related to Project Fuel were included in Consulting, project implementation and management, and other exit costs. Pre-tax Cost of products sold of $0.1 for the six months ended March 31, 2021 related to inventory write-offs associated with Project Fuel, were included in Asset impairment and accelerated depreciation. The following table summarizes the restructuring activities and related accrual for the six months ended March 31, 2022: Utilized October 1, 2021 Charge to Cash Non-Cash March 31, Severance and related benefit costs $ 1.9 $ 3.0 $ (3.0) $ — $ 1.9 Asset write-off and accelerated depreciation — 0.1 — (0.1) — Consulting, project implementation and management, and other exit costs 3.6 2.8 (5.5) — 0.9 Total restructuring $ 5.5 $ 5.9 $ (8.5) $ (0.1) $ 2.8

Income Taxes

Income Taxes	6 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three and six months ended March 31, 2022, the Company had income tax expense of $3.9 and $8.9, respectively, on Earnings before income taxes of $27.1 and $43.3, respectively. The effective tax rate for the three and six months ended March 31, 2022 was 14.4% and 20.5%, respectively. The difference between the federal statutory rate and the effective rate is primarily due to a favorable mix of earnings in low tax jurisdictions and the favorable impact of a change in the Company’s prior estimates. For the three and six months ended March 31, 2021, the Company had income tax expense of $5.1 and $12.6, respectively, on Earnings before income taxes of $19.5 and $44.7, respectively. The effective tax rate for the three and six months ended March 31, 2021 was 26.6% and 28.4%, respectively. The difference between the federal statutory rate and the effective rate for the three and six months ended March 31, 2021 is primarily due to the unfavorable mix of earnings in higher tax rate jurisdictions as well as unfavorable global intangible low-tax income and Internal Revenue Service Code Section 162(m) permanent adjustments.

Earnings per Share

Earnings per Share	6 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent (“RSE”) and performance restricted share equivalent (“PRSE”) awards. The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended Six Months Ended 2022 2021 2022 2021 Basic weighted-average shares outstanding 53.6 54.3 54.0 54.4 Effect of dilutive securities: RSE and PRSE awards 0.7 0.6 0.6 0.5 Total dilutive securities 0.7 0.6 0.6 0.5 Diluted weighted-average shares outstanding 54.3 54.9 54.6 54.9 For the three and six months ended March 31, 2022, the calculation of diluted weighted-average shares outstanding excludes 1.2 of share options. For the three and six months ended March 31, 2022 the calculation excludes 0.1 and 0.4, respectively, of RSE and PRSE awards because the effect of including these awards was anti-dilutive. For the three and six months ended March 31, 2021, the calculation of diluted weighted-average shares outstanding excludes 0.9 of share options because the effect of including these awards was anti-dilutive.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine Total Gross balance at October 1, 2021 $ 967.5 $ 357.6 $ 208.7 $ 1,533.8 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance at October 1, 2021 $ 598.5 $ 355.6 $ 208.7 $ 1,162.8 Changes in the six-month period ended March 31, 2022 Billie acquisition 181.5 — — 181.5 Cumulative translation adjustment (3.9) (0.5) 0.7 (3.7) Gross balance at March 31, 2022 $ 1,145.1 $ 357.1 $ 209.4 $ 1,711.6 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance at March 31, 2022 $ 776.1 $ 355.1 $ 209.4 $ 1,340.6 The following table sets forth intangible assets by class: March 31, 2022 September 30, 2021 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 596.9 $ — $ 596.9 $ 600.8 $ — $ 600.8 Amortizable Trade names and brands $ 339.8 $ 64.8 $ 275.0 $ 256.2 $ 57.7 $ 198.5 Technology and patents 78.7 75.7 3.0 79.1 75.8 3.3 Customer related and other 272.6 123.3 149.3 221.2 117.4 103.8 Total amortizable intangible assets $ 691.1 $ 263.8 $ 427.3 $ 556.5 $ 250.9 $ 305.6 Amortization expense was $7.9 and $14.0 for the three and six months ended March 31, 2022, respectively, and $5.6 and $11.1 for the three and six months ended March 31, 2021, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2022 and for fiscal 2023, 2024, 2025, 2026 and 2027 is $15.5, $30.9, $30.8, $30.8, $30.6 and $30.5, respectively, and $258.2 thereafter. Goodwill and intangible assets deemed to have an indefinite life are not amortized but are instead reviewed annually for impairment of value or when indicators of a potential impairment are present. The Company’s annual impairment testing date is July 1. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. The Company determined there was no triggering event requiring an interim impairment analysis during the six months ended March 31, 2022.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	6 Months Ended
	Mar. 31, 2022
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information March 31, September 30, Inventories Raw materials and supplies $ 67.2 $ 61.3 Work in process 91.3 83.4 Finished products 270.6 201.0 Total inventories $ 429.1 $ 345.7 Other Current Assets Miscellaneous receivables $ 37.4 $ 30.3 Inventory returns receivable 1.2 0.9 Prepaid expenses 77.5 67.3 Value added tax collectible from customers 19.6 19.6 Income taxes receivable 22.9 29.1 Other 9.1 12.9 Total other current assets $ 167.7 $ 160.1 Property, Plant and Equipment Land $ 18.8 $ 19.2 Buildings 143.7 144.5 Machinery and equipment 1,050.8 1,049.0 Capitalized software costs 57.3 57.0 Construction in progress 55.0 44.0 Total gross property, plant and equipment 1,325.6 1,313.7 Accumulated depreciation and amortization (970.2) (951.1) Total property, plant and equipment, net $ 355.4 $ 362.6 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 47.0 $ 33.8 Accrued trade allowances 31.6 34.0 Accrued salaries, vacations and incentive compensation 35.1 66.4 Income taxes payable 10.4 9.8 Returns reserve 48.9 52.7 Restructuring reserve 2.8 5.5 Value added tax payable 7.7 4.6 Deferred compensation 4.6 5.9 Short term lease obligation 11.2 11.0 Customer advance payments 2.1 0.6 Dividends payable 8.0 8.2 Other 84.3 68.3 Total other current liabilities $ 293.7 $ 300.8 Other Liabilities Pensions and other retirement benefits $ 54.8 $ 55.4 Deferred compensation 17.9 22.7 Long term lease obligation 44.4 46.9 Other non-current liabilities 63.1 65.3 Total other liabilities $ 180.2 $ 190.3

Leases

Leases	6 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Leases The Company leases certain offices and manufacturing facilities, warehouses, employee vehicles and certain manufacturing related equipment and determines if an arrangement is or contains a lease at inception. Leases may include options to extend or terminate the lease, and those options are recorded on the Condensed Consolidated Balance Sheet when it is reasonably certain that the Company will exercise one of those options. All recorded leases are classified as operating leases, and lease expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheet. A summary of the Company's lease information is as follows: March 31, September 30, Assets Classification Right of use assets Other assets $ 55.2 $ 57.7 Liabilities Current lease liabilities Other current liabilities $ 11.2 $ 11.0 Long-term lease liabilities Other liabilities 44.4 46.9 Total lease liabilities $ 55.6 $ 57.9 Other information Weighted-average remaining lease term (years) 10 10 Weighted-average incremental borrowing rate 6.4 % 6.3 % Three Months Ended Six Months Ended 2022 2021 2022 2021 Statement of Earnings Lease cost (1) $ 3.3 $ 3.5 $ 6.8 $ 7.4 Other information Leased assets obtained in exchange for new lease liabilities 2.4 13.8 2.9 17.7 Cash paid for amounts included in the measurement of lease liabilities $ 3.3 $ 3.4 $ 6.9 $ 7.4 (1) Lease expense is included in Cost of products sold or SG&A expense based on the nature of the lease. Short-term lease expense is excluded from this amount and is not material. The Company's future lease payments, including reasonably assured renewal options under lease agreements, are as follows: Lease liability repayments March 31, 2022 Remainder of fiscal 2022 $ 6.5 2023 11.4 2024 9.3 2025 8.4 2026 7.0 2027 and thereafter 37.8 Total future minimum lease commitments 80.4 Less: Imputed interest (24.8) Present value of lease liabilities $ 55.6

Accounts Receivable Facility

Accounts Receivable Facility	6 Months Ended
	Mar. 31, 2022
Transfers and Servicing [Abstract]
Accounts receivable facility	Accounts Receivable Facility The Company participates in an uncommitted master accounts receivable purchase agreement dated September 15, 2017 by and between the Company and MUFG Bank, Ltd, formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (the “Accounts Receivable Facility”). Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being de-recognized from the Consolidated Balance Sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase and sale of receivables under the Accounts Receivable Facility is intended to be an absolute and irrevocable transfer without recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company continues to have collection and servicing responsibilities for the receivables sold and receives separate compensation for their servicing. The compensation received is considered acceptable servicing compensation and, as such, the Company does not recognize a servicing asset or liability. On February 7, 2022, the Company entered into the Sixth Amendment to Master Accounts Receivable Purchase Agreement between Edgewell Personal Care, LLC and MUFG Bank, LTD., formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, which increased the maximum receivables sold amount under the Accounts Receivable Facility to $180.0 from $150.0 and amended the pricing index used to determine the purchase price for subject receivables from LIBOR to the Bloomberg Short Term Bank Yield Index (“BSBY”). The applicable margin that is added to the BSBY pricing index specific for each obligor was unchanged. Except as noted above, all other terms, conditions, obligations, covenants or agreements contained in the Accounts Receivable Facility are unmodified in all respects and continue in full force and effect. As of March 31, 2022, the discount rate used to determine the purchase price for the subject receivables shall be based upon BSBY plus a margin applicable to the specified obligor.

Debt

Debt	6 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: March 31, September 30, Senior notes, fixed interest rate of 5.500%, due 2028 $ 750.0 $ 750.0 Senior notes, fixed interest rate of 4.125%, due 2029 500.0 500.0 U.S. revolving credit facility due 2025 179.0 — Total long-term debt, including current maturities 1,429.0 1,250.0 Less unamortized debt issuance costs and discount (1) 14.7 15.8 Total long-term debt $ 1,414.3 $ 1,234.2 (1) At March 31, 2022, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $9.1 and $5.6, respectively. At September 30, 2021, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $9.8 and $6.0, respectively.

Retirement Plans

Retirement Plans	6 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
Retirement Plans	Retirement Plans The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries, which are included in the information presented below. The plans provide retirement benefits based on years of service and compensation. The Company also sponsors or participates in several other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company’s net periodic pension and postretirement costs for these plans were as follows: Three Months Ended Six Months Ended 2022 2021 2022 2021 Service cost $ 1.0 $ 1.1 $ 2.0 $ 2.2 Interest cost 2.6 2.4 5.2 4.9 Expected return on plan assets (5.3) (5.6) (10.6) (11.2) Recognized net actuarial loss 1.6 2.3 3.1 4.6 Net periodic cost $ (0.1) $ 0.2 $ (0.3) $ 0.5 The service cost component of the net periodic cost associated with the Company’s retirement plans is recorded to Cost of products sold and SG&A on the Condensed Consolidated Statement of Earnings and Comprehensive Income. The remaining net periodic cost is recorded to Other income, net on the Condensed Consolidated Statement of Earnings and Comprehensive Income.

Equity

Equity	6 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchases In January 2018, the Company’s Board of Directors (the “Board”) authorized the repurchase of up to 10.0 shares of the Company’s common stock, replacing the previous share repurchase authorization from May 2015. The Company repurchased 1.9 shares of its common stock for $75.4 during the six months ended March 31, 2022 and has 7.8 shares of its common stock available for repurchase in the future under the Board’s authorization. Any future share repurchases may be made in the open market, privately negotiated transactions, or otherwise, and in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs, and other factors. Dividends On February 4, 2022, the Board declared a quarterly cash dividend of $0.15 per common share for the first fiscal quarter. The dividend was paid on April 5, 2022 to stockholders of record as of the close of business on March 8, 2022. Dividends declared during the six months ended March 31, 2022 totaled $16.6. Payments made for dividends during the six months ended March 31, 2022 totaled $16.7.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The following table presents the changes in accumulated other comprehensive loss (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2021 $ (41.8) $ (97.3) $ 2.2 $ (136.9) OCI before reclassifications (1) (15.9) (2.2) 3.3 (14.8) Reclassifications to earnings — 2.3 (1.9) 0.4 Balance at March 31, 2022 $ (57.7) $ (97.2) $ 3.6 $ (151.3) Foreign Pension and Hedging Total Balance at October 1, 2020 $ (47.4) $ (142.1) $ (2.1) $ (191.6) OCI before reclassifications (1) 13.9 (3.9) 1.1 11.1 Reclassifications to earnings — 3.3 2.2 5.5 Balance at March 31, 2021 $ (33.5) $ (142.7) $ 1.2 $ (175.0) (1) OCI is defined as other comprehensive income (loss). The following table presents the reclassifications out of AOCI: Three Months Ended Six Months Ended Affected Line Item in the Details of AOCI Components 2022 2021 2022 2021 Gain / (Loss) on cash flow hedges Foreign exchange contracts $ 1.6 $ (1.8) $ 2.9 $ (3.2) Other income, net 0.5 (0.6) 1.0 (1.0) Income tax provision 1.1 (1.2) $ 1.9 $ (2.2) Amortization of defined benefit pension and postretirement items Actuarial losses $ (1.6) $ (2.3) $ (3.1) $ (4.6) (1) (0.4) (0.7) (0.8) (1.3) Income tax provision (1.2) (1.6) (2.3) $ (3.3) Total reclassifications for the period $ (0.1) $ (2.8) $ (0.4) $ (5.5) (1) These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	6 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management In the course of ordinary business, the Company enters into contractual arrangements (also referred to as derivatives) to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its counterparty netting arrangements. The section below outlines the types of derivatives in place at March 31, 2022 and September 30, 2021, as well as the Company’s objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company’s sales is tied to currencies other than the U.S. dollar, the Company’s reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar, and the Australian dollar. Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local currency at the end of each month. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other income, net. The primary currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar. Cash Flow Hedges At March 31, 2022, the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective by the Company for accounting purposes in offsetting the associated risk. The Company has forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had unrealized pre-tax gains of $5.3 and $3.3 at March 31, 2022 and September 30, 2021, respectively, on these forward currency contracts, which are accounted for as cash flow hedges and included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at March 31, 2022 levels over the next 12 months, the majority of the pre-tax gain included in AOCI at March 31, 2022 is expected to be included in Other income, net. Contract maturities for these hedges extend into fiscal 2023. At March 31, 2022, there were 64 open foreign currency contracts with a total notional value of $127.2. Derivatives not Designated as Hedges The Company has foreign currency derivative contracts, which are not designated as cash flow hedges for accounting purposes, to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures and, thus, are not subject to significant market risk. The change in the estimated fair value of the foreign currency contracts for the three and six months ended March 31, 2022 resulted in gains of $0.6 and $1.7, respectively, compared to $3.0 and $1.9 for the three and six months ended March 31, 2021, respectively, and was recorded in Other income, net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. At March 31, 2022, there were five open foreign currency derivative contracts not designated as cash flow hedges with a total notional value of $39.0. The following table provides estimated fair values of derivative instruments: Fair Value of Assets (1) March 31, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 5.3 $ 3.3 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 1.7 $ 0.5 (1) All derivative assets are presented in Other current assets or Other assets. The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended Six Months Ended 2022 2021 2022 2021 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain recognized in OCI (1) $ 3.1 $ 5.7 $ 4.9 $ 1.7 Gain (loss) reclassified from AOCI into income (1) (2) 1.6 (1.8) 2.9 (3.2) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain recognized in income (2) $ 0.6 $ 3.0 $ 1.7 $ 1.9 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk. (2) Gain (loss) was recorded in Other income, net. The following table provides financial assets and liabilities for balance sheet offsetting: At March 31, 2022 At September 30, 2021 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 7.6 $ (0.7) $ 3.9 $ (0.2) Gross amounts offset in the balance sheet — 0.1 (0.1) 0.1 Net amounts of assets (liabilities) presented in the balance sheet $ 7.6 $ (0.6) $ 3.8 $ (0.1) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets. The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: March 31, September 30, Liabilities at estimated fair value: Deferred compensation $ (22.2) $ (28.4) Derivatives - foreign currency contracts 7.0 3.7 Net liabilities at estimated fair value $ (15.2) $ (24.7) The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. At March 31, 2022 and September 30, 2021, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates, and remaining maturities. At March 31, 2022 and September 30, 2021, the Company had no Level 1 financial assets or liabilities, other than pension plan assets, and no Level 3 financial assets or liabilities at March 31, 2022 and at September 30, 2021. At March 31, 2022 and September 30, 2021, the fair market value of fixed rate long-term debt was $1,157.3 and $1,300.1, respectively, compared to its carrying value of $1,250.0 in each period. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of long-term debt, excluding the U.S. revolving credit facility due 2025 (“Revolving Credit Facility”), has been determined based on Level 2 inputs. Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Revolving Credit Facility, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings, and the Revolving Credit Facility have been determined based on Level 2 inputs.

Segment Data

Segment Data	6 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment Data	Segment Data For an overview of the Company’s segments, refer to Note 1 to Notes to Condensed Consolidated Financial Statements. Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, restructuring charges and certain costs deemed non-recurring in nature, including acquisition and integration costs, value-added tax (“VAT”) settlement costs, Sun Care reformulation costs, and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management’s view on how it evaluates segment performance. The Company’s operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, combined sales force and management teams. The Company applies a fully allocated cost basis in which shared business functions are allocated between the segments. The Company completed the acquisition of Billie on November 29, 2021. Net Sales and Segment Profit associated with Billie products have been reported in the Wet Shave segment since the Acquisition Date. Fiscal 2022 acquisition and integration costs related to the Billie acquisition, while Fiscal 2021 costs related primarily to the Cremo acquisition, which was acquired on September 2, 2020. Segment net sales and profitability are presented below: Three Months Ended Six Months Ended 2022 2021 2022 2021 Net Sales Wet Shave $ 305.0 $ 292.7 $ 591.1 $ 571.8 Sun and Skin Care 183.3 159.5 288.1 262.5 Feminine Care 59.4 67.1 131.8 136.1 Total net sales $ 547.7 $ 519.3 $ 1,011.0 $ 970.4 Segment Profit Wet Shave $ 27.6 $ 45.9 $ 79.1 $ 98.5 Sun and Skin Care 42.3 36.2 46.0 41.4 Feminine Care 1.9 5.6 10.3 14.4 Total segment profit 71.8 87.7 135.4 154.3 General corporate and other expenses (17.2) (13.4) (28.0) (25.5) Restructuring and related costs (3.7) (5.5) (5.9) (9.9) Acquisition and integration costs (1) (1.1) (0.3) (7.1) (3.3) VAT settlement costs (2) — — (3.4) — Sun Care reformulation costs (3) (0.2) — (3.5) — Amortization of intangibles (7.9) (5.6) (14.0) (11.1) Cost of early retirement of long-term debt — (26.1) — (26.1) Interest and other expense, net (14.6) (17.3) (30.2) (33.7) Total earnings before income taxes $ 27.1 $ 19.5 $ 43.3 $ 44.7 (1) Includes pre-tax SG&A of $0.6 and $6.3 for the three and six months ended March 31, 2022, respectively and $0.3 and $2.0 for the three and six months ended March 31, 2021, respectively. Additionally, includes Cost of products sold of $0.5 and $0.8 related to the valuation of acquired inventory for the Billie acquisition for the three and six months ended March 31, 2022, respectively. Cost of products sold includes $1.3 related to the valuation of acquired inventory for the Cremo acquisition for the six months ended March 31, 2021. (2) Includes pre-tax SG&A of $3.4 for the six months ended March 31, 2022 related to the estimated settlement of prior years’ value-added tax audits in Germany. (3) Includes pre-tax COGS of $0.2 and $3.5 for the three and six months ended March 31, 2022, respectively related to the recall and destruction of certain Sun Care products. The following table presents the Company’s net sales by geographic area: Three Months Ended Six Months Ended 2022 2021 2022 2021 Net Sales to Customers United States $ 341.9 $ 301.8 $ 604.4 $ 552.7 International 205.8 217.5 406.6 417.7 Total net sales $ 547.7 $ 519.3 $ 1,011.0 $ 970.4 Supplemental product information is presented below for net sales: Three Months Ended Six Months Ended 2022 2021 2022 2021 Razors and blades $ 275.3 $ 262.4 $ 531.0 $ 508.7 Tampons, pads, and liners 59.4 67.1 131.8 136.1 Sun care products 131.4 103.0 171.6 131.8 Grooming products 34.4 33.1 80.7 76.2 Wipes and other skin care 17.5 23.4 35.8 54.5 Shaving gels and creams 29.7 30.3 60.1 63.1 Total net sales $ 547.7 $ 519.3 $ 1,011.0 $ 970.4

Business Combinations (Tables)

Business Combinations (Tables)	6 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table provides the preliminary allocation of the purchase price related to the Acquisition based upon the fair value of assets and liabilities assumed: Current assets $ 17.0 Goodwill 181.5 Intangible assets 136.0 Other assets, including property, plant and equipment, net 3.2 Current liabilities (6.9) Deferred tax liabilities (21.4) $ 309.4
Business Acquisition, Pro Forma Information	The following summarizes the company's unaudited pro forma consolidated results of operations for the three and six months ended March 31, 2022 and March 31, 2021, as though the Acquisition occurred on October 1, 2020: Three Months Ended Six Months Ended 2022 2021 2022 2021 Pro forma net sales $ 547.7 $ 536.2 $ 1,021.0 $ 1,003.5 Pro forma net earnings 23.9 8.2 38.7 18.4

Restructuring Charges (Tables)

Restructuring Charges (Tables)	6 Months Ended
	Mar. 31, 2022
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	Three Months Ended Six Months Ended Severance and related benefit costs $ 1.7 $ 3.0 Asset write-off and accelerated depreciation 0.1 0.1 Consulting, project implementation and management, and other exit costs 1.9 2.8 Total restructuring $ 3.7 $ 5.9 Pre-tax SG&A of $0.2 for the three and six months ended March 31, 2022, associated with certain information technology enablement expenses and compensation expenses for restructuring programs were included in Consulting, project implementation and management, and other exit costs. Project Fuel Project Fuel was an enterprise-wide transformational initiative launched in fiscal 2018 to improve operational performance and reshape the business’ cost structure. Project Fuel was completed on September 30, 2021. The Company incurred the following restructuring charges for the three and six months ended March 31, 2021: Three Months Ended Six Months Ended Severance and related benefit costs $ 2.0 4.3 Asset write-off and accelerated depreciation 0.1 0.2 Consulting, project implementation and management, and other exit costs 3.4 5.4 Total restructuring $ 5.5 $ 9.9 Pre-tax SG&A of $2.8 and $3.4 for the three and six months ended March 31, 2021, respectively, associated with certain information technology enablement expenses and compensation expenses related to Project Fuel were included in Consulting, project implementation and management, and other exit costs. Pre-tax Cost of products sold of $0.1 for the six months ended March 31, 2021 related to inventory write-offs associated with Project Fuel, were included in Asset impairment and accelerated depreciation.
Schedule of Restructuring Activities and Related Accruals	The following table summarizes the restructuring activities and related accrual for the six months ended March 31, 2022: Utilized October 1, 2021 Charge to Cash Non-Cash March 31, Severance and related benefit costs $ 1.9 $ 3.0 $ (3.0) $ — $ 1.9 Asset write-off and accelerated depreciation — 0.1 — (0.1) — Consulting, project implementation and management, and other exit costs 3.6 2.8 (5.5) — 0.9 Total restructuring $ 5.5 $ 5.9 $ (8.5) $ (0.1) $ 2.8

Earnings per Share (Tables)

Earnings per Share (Tables)	6 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended Six Months Ended 2022 2021 2022 2021 Basic weighted-average shares outstanding 53.6 54.3 54.0 54.4 Effect of dilutive securities: RSE and PRSE awards 0.7 0.6 0.6 0.5 Total dilutive securities 0.7 0.6 0.6 0.5 Diluted weighted-average shares outstanding 54.3 54.9 54.6 54.9

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended	6 Months Ended
	Mar. 31, 2022	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill		The following table sets forth goodwill by segment: Wet Sun and Skin Feminine Total Gross balance at October 1, 2021 $ 967.5 $ 357.6 $ 208.7 $ 1,533.8 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance at October 1, 2021 $ 598.5 $ 355.6 $ 208.7 $ 1,162.8 Changes in the six-month period ended March 31, 2022 Billie acquisition 181.5 — — 181.5 Cumulative translation adjustment (3.9) (0.5) 0.7 (3.7) Gross balance at March 31, 2022 $ 1,145.1 $ 357.1 $ 209.4 $ 1,711.6 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance at March 31, 2022 $ 776.1 $ 355.1 $ 209.4 $ 1,340.6
Schedule of Amortizable Intangible Assets	The following table sets forth intangible assets by class: March 31, 2022 September 30, 2021 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 596.9 $ — $ 596.9 $ 600.8 $ — $ 600.8 Amortizable Trade names and brands $ 339.8 $ 64.8 $ 275.0 $ 256.2 $ 57.7 $ 198.5 Technology and patents 78.7 75.7 3.0 79.1 75.8 3.3 Customer related and other 272.6 123.3 149.3 221.2 117.4 103.8 Total amortizable intangible assets $ 691.1 $ 263.8 $ 427.3 $ 556.5 $ 250.9 $ 305.6

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	6 Months Ended
	Mar. 31, 2022
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	March 31, September 30, Inventories Raw materials and supplies $ 67.2 $ 61.3 Work in process 91.3 83.4 Finished products 270.6 201.0 Total inventories $ 429.1 $ 345.7 Other Current Assets Miscellaneous receivables $ 37.4 $ 30.3 Inventory returns receivable 1.2 0.9 Prepaid expenses 77.5 67.3 Value added tax collectible from customers 19.6 19.6 Income taxes receivable 22.9 29.1 Other 9.1 12.9 Total other current assets $ 167.7 $ 160.1 Property, Plant and Equipment Land $ 18.8 $ 19.2 Buildings 143.7 144.5 Machinery and equipment 1,050.8 1,049.0 Capitalized software costs 57.3 57.0 Construction in progress 55.0 44.0 Total gross property, plant and equipment 1,325.6 1,313.7 Accumulated depreciation and amortization (970.2) (951.1) Total property, plant and equipment, net $ 355.4 $ 362.6 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 47.0 $ 33.8 Accrued trade allowances 31.6 34.0 Accrued salaries, vacations and incentive compensation 35.1 66.4 Income taxes payable 10.4 9.8 Returns reserve 48.9 52.7 Restructuring reserve 2.8 5.5 Value added tax payable 7.7 4.6 Deferred compensation 4.6 5.9 Short term lease obligation 11.2 11.0 Customer advance payments 2.1 0.6 Dividends payable 8.0 8.2 Other 84.3 68.3 Total other current liabilities $ 293.7 $ 300.8 Other Liabilities Pensions and other retirement benefits $ 54.8 $ 55.4 Deferred compensation 17.9 22.7 Long term lease obligation 44.4 46.9 Other non-current liabilities 63.1 65.3 Total other liabilities $ 180.2 $ 190.3

Leases (Tables)

Leases (Tables)	6 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Summary of Lease Information	A summary of the Company's lease information is as follows: March 31, September 30, Assets Classification Right of use assets Other assets $ 55.2 $ 57.7 Liabilities Current lease liabilities Other current liabilities $ 11.2 $ 11.0 Long-term lease liabilities Other liabilities 44.4 46.9 Total lease liabilities $ 55.6 $ 57.9 Other information Weighted-average remaining lease term (years) 10 10 Weighted-average incremental borrowing rate 6.4 % 6.3 % Three Months Ended Six Months Ended 2022 2021 2022 2021 Statement of Earnings Lease cost (1) $ 3.3 $ 3.5 $ 6.8 $ 7.4 Other information Leased assets obtained in exchange for new lease liabilities 2.4 13.8 2.9 17.7 Cash paid for amounts included in the measurement of lease liabilities $ 3.3 $ 3.4 $ 6.9 $ 7.4
Lessee, Operating Lease, Liability, Maturity	The Company's future lease payments, including reasonably assured renewal options under lease agreements, are as follows: Lease liability repayments March 31, 2022 Remainder of fiscal 2022 $ 6.5 2023 11.4 2024 9.3 2025 8.4 2026 7.0 2027 and thereafter 37.8 Total future minimum lease commitments 80.4 Less: Imputed interest (24.8) Present value of lease liabilities $ 55.6

Debt (Tables)

Debt (Tables)	6 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: March 31, September 30, Senior notes, fixed interest rate of 5.500%, due 2028 $ 750.0 $ 750.0 Senior notes, fixed interest rate of 4.125%, due 2029 500.0 500.0 U.S. revolving credit facility due 2025 179.0 — Total long-term debt, including current maturities 1,429.0 1,250.0 Less unamortized debt issuance costs and discount (1) 14.7 15.8 Total long-term debt $ 1,414.3 $ 1,234.2 (1) At March 31, 2022, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $9.1 and $5.6, respectively. At September 30, 2021, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $9.8 and $6.0, respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	6 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Cost (Benefit)	The Company’s net periodic pension and postretirement costs for these plans were as follows: Three Months Ended Six Months Ended 2022 2021 2022 2021 Service cost $ 1.0 $ 1.1 $ 2.0 $ 2.2 Interest cost 2.6 2.4 5.2 4.9 Expected return on plan assets (5.3) (5.6) (10.6) (11.2) Recognized net actuarial loss 1.6 2.3 3.1 4.6 Net periodic cost $ (0.1) $ 0.2 $ (0.3) $ 0.5

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in accumulated other comprehensive loss (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2021 $ (41.8) $ (97.3) $ 2.2 $ (136.9) OCI before reclassifications (1) (15.9) (2.2) 3.3 (14.8) Reclassifications to earnings — 2.3 (1.9) 0.4 Balance at March 31, 2022 $ (57.7) $ (97.2) $ 3.6 $ (151.3) Foreign Pension and Hedging Total Balance at October 1, 2020 $ (47.4) $ (142.1) $ (2.1) $ (191.6) OCI before reclassifications (1) 13.9 (3.9) 1.1 11.1 Reclassifications to earnings — 3.3 2.2 5.5 Balance at March 31, 2021 $ (33.5) $ (142.7) $ 1.2 $ (175.0) (1) OCI is defined as other comprehensive income (loss).
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: Three Months Ended Six Months Ended Affected Line Item in the Details of AOCI Components 2022 2021 2022 2021 Gain / (Loss) on cash flow hedges Foreign exchange contracts $ 1.6 $ (1.8) $ 2.9 $ (3.2) Other income, net 0.5 (0.6) 1.0 (1.0) Income tax provision 1.1 (1.2) $ 1.9 $ (2.2) Amortization of defined benefit pension and postretirement items Actuarial losses $ (1.6) $ (2.3) $ (3.1) $ (4.6) (1) (0.4) (0.7) (0.8) (1.3) Income tax provision (1.2) (1.6) (2.3) $ (3.3) Total reclassifications for the period $ (0.1) $ (2.8) $ (0.4) $ (5.5) (1) These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	6 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Assets (1) March 31, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 5.3 $ 3.3 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 1.7 $ 0.5 (1) All derivative assets are presented in Other current assets or Other assets.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended Six Months Ended 2022 2021 2022 2021 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain recognized in OCI (1) $ 3.1 $ 5.7 $ 4.9 $ 1.7 Gain (loss) reclassified from AOCI into income (1) (2) 1.6 (1.8) 2.9 (3.2) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain recognized in income (2) $ 0.6 $ 3.0 $ 1.7 $ 1.9 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk.
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: At March 31, 2022 At September 30, 2021 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 7.6 $ (0.7) $ 3.9 $ (0.2) Gross amounts offset in the balance sheet — 0.1 (0.1) 0.1 Net amounts of assets (liabilities) presented in the balance sheet $ 7.6 $ (0.6) $ 3.8 $ (0.1) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: March 31, September 30, Liabilities at estimated fair value: Deferred compensation $ (22.2) $ (28.4) Derivatives - foreign currency contracts 7.0 3.7 Net liabilities at estimated fair value $ (15.2) $ (24.7)

Segment Data (Tables)

Segment Data (Tables)	6 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended Six Months Ended 2022 2021 2022 2021 Net Sales Wet Shave $ 305.0 $ 292.7 $ 591.1 $ 571.8 Sun and Skin Care 183.3 159.5 288.1 262.5 Feminine Care 59.4 67.1 131.8 136.1 Total net sales $ 547.7 $ 519.3 $ 1,011.0 $ 970.4 Segment Profit Wet Shave $ 27.6 $ 45.9 $ 79.1 $ 98.5 Sun and Skin Care 42.3 36.2 46.0 41.4 Feminine Care 1.9 5.6 10.3 14.4 Total segment profit 71.8 87.7 135.4 154.3 General corporate and other expenses (17.2) (13.4) (28.0) (25.5) Restructuring and related costs (3.7) (5.5) (5.9) (9.9) Acquisition and integration costs (1) (1.1) (0.3) (7.1) (3.3) VAT settlement costs (2) — — (3.4) — Sun Care reformulation costs (3) (0.2) — (3.5) — Amortization of intangibles (7.9) (5.6) (14.0) (11.1) Cost of early retirement of long-term debt — (26.1) — (26.1) Interest and other expense, net (14.6) (17.3) (30.2) (33.7) Total earnings before income taxes $ 27.1 $ 19.5 $ 43.3 $ 44.7 (1) Includes pre-tax SG&A of $0.6 and $6.3 for the three and six months ended March 31, 2022, respectively and $0.3 and $2.0 for the three and six months ended March 31, 2021, respectively. Additionally, includes Cost of products sold of $0.5 and $0.8 related to the valuation of acquired inventory for the Billie acquisition for the three and six months ended March 31, 2022, respectively. Cost of products sold includes $1.3 related to the valuation of acquired inventory for the Cremo acquisition for the six months ended March 31, 2021. (2) Includes pre-tax SG&A of $3.4 for the six months ended March 31, 2022 related to the estimated settlement of prior years’ value-added tax audits in Germany. (3) Includes pre-tax COGS of $0.2 and $3.5 for the three and six months ended March 31, 2022, respectively related to the recall and destruction of certain Sun Care products.
Schedule of Sales by Geographic Area	The following table presents the Company’s net sales by geographic area: Three Months Ended Six Months Ended 2022 2021 2022 2021 Net Sales to Customers United States $ 341.9 $ 301.8 $ 604.4 $ 552.7 International 205.8 217.5 406.6 417.7 Total net sales $ 547.7 $ 519.3 $ 1,011.0 $ 970.4
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended Six Months Ended 2022 2021 2022 2021 Razors and blades $ 275.3 $ 262.4 $ 531.0 $ 508.7 Tampons, pads, and liners 59.4 67.1 131.8 136.1 Sun care products 131.4 103.0 171.6 131.8 Grooming products 34.4 33.1 80.7 76.2 Wipes and other skin care 17.5 23.4 35.8 54.5 Shaving gels and creams 29.7 30.3 60.1 63.1 Total net sales $ 547.7 $ 519.3 $ 1,011.0 $ 970.4

Background and Basis of Prese_2

Background and Basis of Presentation (Details) $ in Millions	3 Months Ended	6 Months Ended
	Dec. 31, 2021USD ($)	Mar. 31, 2022USD ($)country	Mar. 31, 2021USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which Edgewell operates | country		20
Number of countries with retail operations | country		50
Repayments of Long-term Lines of Credit | $		$ 220	$ 0
Restatement Adjustment
Repayments of Long-term Lines of Credit | $	$ (93)

Business Combinations (Schedule

Business Combinations (Schedule of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Millions	Mar. 31, 2022	Nov. 29, 2021	Sep. 30, 2021
Business Acquisition [Line Items]
Goodwill acquired	$ 1,340.6		$ 1,162.8
Billie
Business Acquisition [Line Items]
Current assets acquired		$ 17
Goodwill acquired		181.5
Business combinations, intangible assets acquired		136
Property, plant and equipment acquired		3.2
Current liabilities assumed		(6.9)
Deferred tax liabilities acquired		(21.4)
Business combinations, assets acquired, goodwill and liabilities assumed, net		$ 309.4

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Millions	Nov. 29, 2021	Mar. 31, 2022		Mar. 31, 2021		Mar. 31, 2022	Mar. 31, 2021
Business Acquisition [Line Items]
Acquisition of Billie, net of cash acquired	$ 309.4					$ 309.4	$ 0
Acquisition and integration costs		$ 1.1	[1]	$ 0.3	[1]	7.1	3.3
Proforma net sales		547.7		536.2		1,021	1,003.5
Pro forma amortization expense				$ 2.1		1.3	$ 4.3
Pro forma acquisition costs		1.1				7.1
Billie
Business Acquisition [Line Items]
Acquisition close date	Nov. 29, 2021
Weighted average useful life of acquired intangible assets	19 years
Proforma net sales						40.9
Business combination, loss of acquiree since acquisition						(4.4)
Billie | Selling, general and administrative expenses
Business Acquisition [Line Items]
Acquisition and integration costs		0.6				6.3
Billie | Cost of products sold
Business Acquisition [Line Items]
Acquisition and integration costs		$ 0.5				$ 0.8
[1]	Includes pre-tax SG&A of $0.6 and $6.3 for the three and six months ended March 31, 2022, respectively and $0.3 and $2.0 for the three and six months ended March 31, 2021, respectively. Additionally, includes Cost of products sold of $0.5 and $0.8 related to the valuation of acquired inventory for the Billie acquisition for the three and six months ended March 31, 2022, respectively. Cost of products sold includes $1.3 related to the valuation of acquired inventory for the Cremo acquisition for the six months ended March 31, 2021.

Business Combinations (Schedu_2

Business Combinations (Schedule of Pro Forma Financial Information) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Business Combinations [Abstract]
Proforma net sales	$ 547.7	$ 536.2	$ 1,021	$ 1,003.5
Proforma net earnings	$ 23.9	$ 8.2	$ 38.7	$ 18.4

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Restructuring Cost and Reserve [Line Items]
Severance Costs	$ 1.7	$ 2	$ 3	$ 4.3
Asset Impairment and Accelerated Depreciation	0.1	0.1	0.1	0.2
Other Restructuring Costs	1.9	3.4	2.8	5.4
Total restructuring	3.7	5.5	$ 5.9	9.9
IT enablement | Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Total restructuring	$ 0.2	$ 2.8		3.4
Inventory obsolescence | Cost of products sold
Restructuring Cost and Reserve [Line Items]
Total restructuring				$ 0.1

Restructuring Charges (Schedu_2

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Restructuring Reserve [Roll Forward]
Beginning Balance			$ 5.5
Restructuring and related costs	$ 3.7	$ 5.5	5.9	$ 9.9
Utilized - Cash Payments			(8.5)
Utilized - Non-Cash			(0.1)
Ending Balance	2.8		2.8
Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance			1.9
Restructuring and related costs			3
Utilized - Cash Payments			(3)
Utilized - Non-Cash			0
Ending Balance	1.9		1.9
Asset Impairment and Accelerated Depreciation [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance			0
Restructuring and related costs			0.1
Utilized - Cash Payments			0
Utilized - Non-Cash			(0.1)
Ending Balance	0		0
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance			3.6
Restructuring and related costs			2.8
Utilized - Cash Payments			(5.5)
Utilized - Non-Cash			0
Ending Balance	$ 0.9		$ 0.9

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income tax provision	$ 3.9	$ 5.1	$ 8.9	$ 12.6
Earnings before income taxes	$ 27.1	$ 19.5	$ 43.3	$ 44.7
Effective tax rate	14.40%	26.60%	20.50%	28.40%

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	53.6	54.3	54	54.4
Effect of dilutive securities (in shares)	0.7	0.6	0.6	0.5
Diluted weighted-average shares outstanding (in shares)	54.3	54.9	54.6	54.9
RSE and PRSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	0.7	0.6	0.6	0.5
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	1.2	0.9	1.2	0.9
RSE and PRSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.1		0.4

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2022	Sep. 30, 2021
Goodwill [Line Items]
Goodwill, Gross	$ 1,711.6	$ 1,533.8
Accumulated goodwill impairment loss	371	371
Goodwill [Roll Forward]
Beginning balance	1,162.8
Goodwill, Acquired During Period	181.5
Cumulative translation adjustment	3.7
Ending balance	1,340.6
Wet Shave
Goodwill [Line Items]
Goodwill, Gross	1,145.1	967.5
Accumulated goodwill impairment loss	369	369
Goodwill [Roll Forward]
Beginning balance	598.5
Goodwill, Acquired During Period	181.5
Cumulative translation adjustment	3.9
Ending balance	776.1
Sun and Skin Care
Goodwill [Line Items]
Goodwill, Gross	357.1	357.6
Accumulated goodwill impairment loss	2	2
Goodwill [Roll Forward]
Beginning balance	355.6
Goodwill, Acquired During Period	0
Cumulative translation adjustment	0.5
Ending balance	355.1
Feminine Care
Goodwill [Line Items]
Goodwill, Gross	209.4	208.7
Accumulated goodwill impairment loss	0	$ 0
Goodwill [Roll Forward]
Beginning balance	208.7
Goodwill, Acquired During Period	0
Cumulative translation adjustment	(0.7)
Ending balance	$ 209.4

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 691.1		$ 691.1		$ 556.5
Amortizable intangible assets, accumulated amortization	263.8		263.8		250.9
Amortizable intangible assets, net	427.3		427.3		305.6
Amortization of intangibles	7.9	$ 5.6	14	$ 11.1
Amortizable intangible assets, amortization expense, remainder of 2022	15.5		15.5
Amortizable intangible assets, amortization expense, fiscal 2023	30.9		30.9
Amortizable intangible assets, amortization expense, fiscal 2024	30.8		30.8
Amortizable intangible assets, amortization expense, fiscal 2025	30.8		30.8
Amortizable intangible assets, amortization expense, fiscal 2026	30.6		30.6
Amortizable intangible assets, amortization expense, fiscal 2027	30.5		30.5
Amortizable intangible assets, amortization expense, after fiscal 2027	258.2		258.2
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	596.9		596.9		600.8
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	339.8		339.8		256.2
Amortizable intangible assets, accumulated amortization	64.8		64.8		57.7
Amortizable intangible assets, net	275		275		198.5
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	78.7		78.7		79.1
Amortizable intangible assets, accumulated amortization	75.7		75.7		75.8
Amortizable intangible assets, net	3		3		3.3
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	272.6		272.6		221.2
Amortizable intangible assets, accumulated amortization	123.3		123.3		117.4
Amortizable intangible assets, net	$ 149.3		$ 149.3		$ 103.8

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Mar. 31, 2022	Sep. 30, 2021
Inventories
Raw materials and supplies	$ 67.2	$ 61.3
Work in process	91.3	83.4
Finished products	270.6	201
Total inventories	429.1	345.7
Other Current Assets
Miscellaneous receivables	37.4	30.3
Inventory returns receivable	1.2	0.9
Prepaid expenses	77.5	67.3
Value added tax collectible from customers	19.6	19.6
Income taxes receivable	22.9	29.1
Other	9.1	12.9
Total other current assets	167.7	160.1
Property, Plant and Equipment
Land	18.8	19.2
Buildings	143.7	144.5
Machinery and equipment	1,050.8	1,049
Capitalized software costs	57.3	57
Construction in progress	55	44
Total gross property, plant and equipment	1,325.6	1,313.7
Accumulated depreciation and amortization	(970.2)	(951.1)
Total property, plant and equipment, net	355.4	362.6
Other Current Liabilities
Accrued advertising, sales promotion and allowances	47	33.8
Accrued trade allowances	31.6	34
Accrued salaries, vacations and incentive compensation	35.1	66.4
Income taxes payable	10.4	9.8
Returns reserve	48.9	52.7
Restructuring reserve	2.8	5.5
Value added tax payable	7.7	4.6
Deferred compensation	4.6	5.9
Short term lease obligation	11.2	11
Customer advance payments	2.1	0.6
Dividends payable	8	8.2
Other	84.3	68.3
Total other current liabilities	293.7	300.8
Other Liabilities
Pensions and other retirement benefits	54.8	55.4
Deferred compensation	17.9	22.7
Noncurrent lease obligation	44.4	46.9
Other non-current liabilities	63.1	65.3
Total other liabilities	$ 180.2	$ 190.3

Leases (Summary of Lease Inform

Leases (Summary of Lease Information) (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Mar. 31, 2022		Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021
Leases [Abstract]
Operating lease, right-of-use asset	$ 55.2			$ 55.2		$ 57.7
Short term lease obligation	11.2			11.2		11
Noncurrent lease obligation	44.4			44.4		46.9
Total lease obligation	$ 55.6			$ 55.6		$ 57.9
Operating lease, weighted average remaining lease term	10 years			10 years		10 years
Operating lease, weighted average discount rate, percent	6.40%			6.40%		6.30%
Operating lease, expense	$ 3.3	[1]	$ 3.5	$ 6.8	$ 7.4
Right-of-use asset obtained in exchange for operating lease liability	2.4		13.8	2.9	17.7
Operating lease, payments	$ 3.3		$ 3.4	$ 6.9	$ 7.4
[1]	Lease expense is included in Cost of products sold or SG&A expense based on the nature of the lease. Short-term lease expense is excluded from this amount and is not material.

Leases (Operating Lease Payment

Leases (Operating Lease Payment Schedule) (Details) - USD ($) $ in Millions	Mar. 31, 2022	Sep. 30, 2021
Leases [Abstract]
Lessee, operating lease, payment due current year	$ 6.5
Lessee, operating lease, payment due year two	11.4
Lessee, operating lease, payment due year three	9.3
Lessee, operating lease, payment due year four	8.4
Lessee, operating lease, payment due year five	7
Lessee, operating lease, payment due after year five	37.8
Lessee, operating lease, payments due	80.4
Lessee, operating lease, undiscounted excess amount	24.8
Total lease obligation	$ 55.6	$ 57.9
Operating lease, weighted average remaining lease term	10 years	10 years

Accounts Receivable Facility (N

Accounts Receivable Facility (Narrative) (Details) - Accounts receivable sales agreement - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021
Transfer of Financial Assets Accounted for as Sales [Line Items]
Accounts receivable sold through AR Facility	$ 282	$ 201.9	$ 437.2	$ 340.3
Transfer of accounts receivable, sales amount derecognized	134.5		134.5		$ 91.1
Loss on sale of accounts receivable	$ 0.3	$ 0.2	$ 0.5	$ 0.4

Debt (Details)

Debt (Details) - USD ($) $ in Millions		Mar. 31, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 1,429	$ 1,250
Long-term debt		1,414.3	1,234.2
Notes payable		25.8	26.5
Unamortized debt issuance costs	[1]	14.7	15.8
Senior notes | Senior Notes, Due 2028
Debt Instrument [Line Items]
Total long-term debt, including current maturities		750	750
Unamortized debt issuance costs		9.1	9.8
Senior notes | Senior Notes, Due 2029
Debt Instrument [Line Items]
Total long-term debt, including current maturities		500	500
Unamortized debt issuance costs		5.6	6
Revolving credit facility
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 179	$ 0
[1]	At March 31, 2022, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $9.1 and $5.6, respectively. At September 30, 2021, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $9.8 and $6.0, respectively.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Retirement Benefits [Abstract]
Service cost	$ 1	$ 1.1	$ 2	$ 2.2
Interest cost	2.6	2.4	5.2	4.9
Expected return on plan assets	(5.3)	(5.6)	(10.6)	(11.2)
Recognized net actuarial loss	1.6	2.3	3.1	4.6
Net periodic cost	$ (0.1)	$ 0.2	$ (0.3)	$ 0.5

Equity (Details)

Equity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended			6 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Mar. 31, 2022	Mar. 31, 2021	Jan. 26, 2018
Equity [Abstract]
Share repurchase authorization						10
Treasury shares repurchased (in shares)				1.9
Treasury shares repurchased (in usd)	$ 50.9	$ 24.5	$ 9.2	$ 75.4
Share repurchase authorization, remaining	7.8			7.8
Dividends declared (per share)	$ 0.15
Dividends declared				$ 16.6
Dividends to common shareholders				$ (16.7)	$ (8.4)

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		6 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (136.9)	$ (191.6)
OCI before reclassifications	[1]	(14.8)	11.1
Reclassifications to earnings		0.4	5.5
Ending balance		(151.3)	(175)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(41.8)	(47.4)
OCI before reclassifications	[1]	(15.9)	13.9
Reclassifications to earnings		0	0
Ending balance		(57.7)	(33.5)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(97.3)	(142.1)
OCI before reclassifications	[1]	(2.2)	(3.9)
Reclassifications to earnings		2.3	3.3
Ending balance		(97.2)	(142.7)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		2.2	(2.1)
OCI before reclassifications	[1]	3.3	1.1
Reclassifications to earnings		(1.9)	2.2
Ending balance		$ 3.6	$ 1.2
[1]	OCI is defined as other comprehensive income (loss).

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 31, 2022		Mar. 31, 2021		Mar. 31, 2022	Mar. 31, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings					$ 0.4	$ 5.5
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedge, reclassification to earnings, tax	$ 0.5		$ (0.6)		1	(1)
Other comprehensive income, reclassification to earnings, cash flow hedges, after tax	1.1		(1.2)		1.9	(2.2)
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	(1.6)	[1]	(2.3)	[1]	(3.1)	(4.6)
Amortization of defined benefit pension and postretirement items, tax	(0.4)		(0.7)		(0.8)	(1.3)
Amortization of defined benefit pension and postretirement items, after tax	(1.2)		(1.6)		(2.3)	(3.3)
Reclassifications to earnings	(0.1)		(2.8)		(0.4)	(5.5)
Other expense (income), net | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax	$ 1.6		$ (1.8)		$ 2.9	$ (3.2)
[1]	These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 31, 2022USD ($)contracts		Mar. 31, 2021USD ($)	[1]	Mar. 31, 2022USD ($)contracts	Mar. 31, 2021USD ($)	Sep. 30, 2021USD ($)
Derivative [Line Items]
Long-term debt	$ 1,429				$ 1,429		$ 1,250
Fixed rate
Derivative [Line Items]
Long-term debt	1,250				1,250		1,250
Fair value of long-term debt	$ 1,157.3				$ 1,157.3		1,300.1
Not designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts	5				5
Derivative, notional amount	$ 39				$ 39
Cash flow hedge | Designated as hedge | FX contract
Derivative [Line Items]
Estimated fair value of derivative	$ 5.3				$ 5.3		$ 3.3
Open foreign currency contracts | contracts	64				64
Derivative, notional amount	$ 127.2				$ 127.2
Other expense (income), net | Not designated as hedge | FX contract
Derivative [Line Items]
Gain (loss) recognized in income	$ 0.6	[1]	$ 3		$ 1.7	$ 1.9
[1]	Gain (loss) was recorded in Other income, net.

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		Mar. 31, 2022	Sep. 30, 2021
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 1.7	$ 0.5
Cash flow hedge | Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 5.3	$ 3.3
[1]	All derivative assets are presented in Other current assets or Other assets.

Financial Instruments and Ris_5

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 31, 2022		Mar. 31, 2021		Mar. 31, 2022	Mar. 31, 2021
Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	$ 3.1	[1]	$ 5.7	[1]	$ 4.9	$ 1.7
Other expense (income), net | Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from AOCI into income (effective portion)	1.6	[1],[2]	(1.8)	[1],[2]	2.9	(3.2)
Other expense (income), net | Not designated as hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	$ (0.6)	[2]	$ (3)	[2]	$ (1.7)	$ (1.9)
[1]	Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk.
[2]	Gain (loss) was recorded in Other income, net.

Financial Instruments and Ris_6

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions		Mar. 31, 2022	Sep. 30, 2021
Derivative [Line Items]
Gross amounts of recognized assets	[1]	$ 7.6	$ 3.9
Gross amounts of recognized liabilities	[2]	(0.7)	(0.2)
Gross amounts offset in the balance sheet	[1]	0	(0.1)
Gross amounts offset in the balance sheet	[2]	0.1	0.1
Net amounts of assets presented in the balance sheet	[1]	7.6	3.8
Net amounts of liabilities presented in the balance sheet	[2]	$ (0.6)	$ (0.1)
[1]	All derivative assets are presented in Other current assets or Other assets.
[2]	All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_7

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Mar. 31, 2022	Sep. 30, 2021
Derivative [Line Items]
Deferred compensation	$ (22.2)	$ (28.4)
Derivatives - foreign currency contracts	7	3.7
Net liabilities at estimated fair value	$ (15.2)	$ (24.7)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 31, 2022		Mar. 31, 2021		Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Net sales	$ 547.7		$ 519.3		$ 1,011	$ 970.4
Segment profit	41.7		62.9		73.5	104.5
Restructuring and related costs	3.7		5.5		5.9	9.9
Acquisition and integration costs	1.1	[1]	0.3	[1]	7.1	3.3
VAT settlement costs	0	[2]	0	[2]	3.4	0
Sun Care reformulation costs	0.2	[3]	0	[3]	3.5	0
Amortization of intangibles	7.9		5.6		14	11.1
Cost of early retirement of long-term debt	0		(26.1)		0	(26.1)
Interest and other expense, net	14.6		17.3		30.2	33.7
Earnings before income taxes	27.1		19.5		43.3	44.7
Wet Shave
Segment Reporting Information [Line Items]
Net sales	305		292.7		591.1	571.8
Segment profit	27.6		45.9		79.1	98.5
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales	183.3		159.5		288.1	262.5
Segment profit	42.3		36.2		46	41.4
Feminine Care
Segment Reporting Information [Line Items]
Net sales	59.4		67.1		131.8	136.1
Segment profit	1.9		5.6		10.3	14.4
Total Segments
Segment Reporting Information [Line Items]
Segment profit	71.8		87.7		135.4	154.3
Corporate
Segment Reporting Information [Line Items]
General corporate and other expenses	17.2		13.4		28	25.5
Selling, general and administrative expenses | Cremo
Segment Reporting Information [Line Items]
Acquisition and integration costs			$ 0.3			$ 2
Selling, general and administrative expenses | Billie
Segment Reporting Information [Line Items]
Acquisition and integration costs	0.6				6.3
Cost of products sold | Cremo
Segment Reporting Information [Line Items]
Acquisition and integration costs					1.3
Cost of products sold | Billie
Segment Reporting Information [Line Items]
Acquisition and integration costs	$ 0.5				$ 0.8
[1]	Includes pre-tax SG&A of $0.6 and $6.3 for the three and six months ended March 31, 2022, respectively and $0.3 and $2.0 for the three and six months ended March 31, 2021, respectively. Additionally, includes Cost of products sold of $0.5 and $0.8 related to the valuation of acquired inventory for the Billie acquisition for the three and six months ended March 31, 2022, respectively. Cost of products sold includes $1.3 related to the valuation of acquired inventory for the Cremo acquisition for the six months ended March 31, 2021.
[2]	Includes pre-tax SG&A of $3.4 for the six months ended March 31, 2022 related to the estimated settlement of prior years’ value-added tax audits in Germany.
[3]	Includes pre-tax COGS of $0.2 and $3.5 for the three and six months ended March 31, 2022, respectively related to the recall and destruction of certain Sun Care products.

Segment Data Segment Data (Sche

Segment Data Segment Data (Schedule of Sales by Geographical Area) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Revenue from External Customer [Line Items]
Net sales	$ 547.7	$ 519.3	$ 1,011	$ 970.4
United States
Revenue from External Customer [Line Items]
Net sales	341.9	301.8	604.4	552.7
International
Revenue from External Customer [Line Items]
Net sales	$ 205.8	$ 217.5	$ 406.6	$ 417.7

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Revenue from External Customer [Line Items]
Net sales	$ 547.7	$ 519.3	$ 1,011	$ 970.4
Razors and blades
Revenue from External Customer [Line Items]
Net sales	275.3	262.4	531	508.7
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	59.4	67.1	131.8	136.1
Sun care products
Revenue from External Customer [Line Items]
Net sales	131.4	103	171.6	131.8
Grooming products
Revenue from External Customer [Line Items]
Net sales	34.4	33.1	80.7	76.2
Wipes and other skin care products
Revenue from External Customer [Line Items]
Net sales	17.5	23.4	35.8	54.5
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	$ 29.7	$ 30.3	$ 60.1	$ 63.1